Overview

Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis

Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
Investigation aimed to explore the efficacy of a topical Sertaconazole cream 2% in patients with skin alterations associated with atopic dermatitis
Phase:
Phase 2
Details
Lead Sponsor:
Spirig Pharma Ltd.
Treatments:
Sertaconazole